Exchange: OTC·Updated 02:31 PM EST

DSNKY Daiichi Sankyo Company

$17.36
$0.074
(0.42%)
Today
Reported EarningsOct 30
Mkt Cap$31.76B
Vol69,156.00

About DSNKY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan.
50

Neutral Sentiment

How do you feel about DSNKY?

Advertisement|Remove ads.